Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 60 of the 60 references it cites were found in a registry or an index.

Dietary Supplementation with 20-Hydroxyecdysone Ameliorates Hepatic Steatosis and Reduces White Adipose Tissue Mass in Ovariectomized Rats Fed a High-Fat, High-Fructose Diet

Open access

Abstract

Metabolic dysfunction-associated fatty liver disease (MAFLD) is defined as hepatic steatosis in combination with overweight, diabetes, or other metabolic risk factors. MAFLD affects a significant number of the global population and imposes substantial clinical and economic burdens. With no approved pharmacotherapy, current treatment options are limited to diet and exercise. Therefore, the development of medicines for MAFLD treatment or prevention is necessary. 20-Hydroxyecdysone (20E) is a natural steroid found in edible plants and has been shown to improve metabolism and dyslipidemia. Therefore, it may be useful for MAFLD treatment. Here, we aimed to determine how dietary supplementation with 20E affects fat accumulation and lipogenesis in the liver and adipose tissue of ovariectomized rats fed a high-fat, high-fructose diet (OHFFD). We found that 20E reduced hepatic triglyceride content and visceral fat deposition. 20E increased the phosphorylation of AMP-activated protein kinase and acetyl CoA carboxylase while reducing the expression of fatty acid synthase in the liver and adipose tissue. Additionally, 20E increased hepatic expression of carnitine palmitoyltransferase-1 and reduced adipose expression of sterol regulatory element-binding protein-1. In conclusion, 20E demonstrated beneficial effects in rats with OHFFD-induced MAFLD. These findings suggest that 20E may represent a promising option for MAFLD prevention or treatment.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3390/biomedicines11072071

Cites

60 of 60 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Effects of 20-hydroxyecdysone (20E) and pioglitazone (PIO) treatment on body weight, total calories intake, and visceral fat mass in ovariectomized rats fed a high-fat, high-fructose diet (HFFD). The (A) Mean weekly body mass, (B) Total caloric intake, (C) Mesenteric fat pad mass, (D) Retroperitoneal fat pad mass, and (E) Periovarian fat pad mass of sham-operated rats (Sham) fed a control diet, ovariectomized (OVX) rats fed a high-fat, high-fructose diet (OHFFD), OVX rats fed an HFFD and administered 20-hydroxyecdysone (OHFFD + 20E) at a dose of 5, 10, or 20 mg/kg, and OVX rats fed an HFFD and administered pioglitazone (OHFFD + PIO). Data are mean ± SEM for six animals/group. # p < 0.0001 (Sham vs. OHFFD); § p < 0.05 (OHFFD vs. OHFFD + 20E). * p < 0.05, ** p < 0.01, and *** p < 0.001 between the indicated groups.
Figure 1 Effects of 20-hydroxyecdysone (20E) and pioglitazone (PIO) treatment on body weight, total calories intake, and visceral fat mass in ovariectomized rats fed a high-fat, high-fructose diet (HFFD). The (A) Mean weekly body mass, (B) Total caloric intake, (C) Mesenteric fat pad mass, (D) Retroperitoneal fat pad mass, and (E) Periovarian fat pad mass of sham-operated rats (Sham) fed a control diet, ovariectomized (OVX) rats fed a high-fat, high-fructose diet (OHFFD), OVX rats fed an HFFD and administered 20-hydroxyecdysone (OHFFD + 20E) at a dose of 5, 10, or 20 mg/kg, and OVX rats fed an HFFD and administered pioglitazone (OHFFD + PIO). Data are mean ± SEM for six animals/group. # p < 0.0001 (Sham vs. OHFFD); § p < 0.05 (OHFFD vs. OHFFD + 20E). * p < 0.05, ** p < 0.01, and *** p < 0.001 between the indicated groups.CC BY · PubMed Central
Figure 2 Effect of 20-hydroxyecdysone (20E) and pioglitazone (PIO) treatment on hepatic fat accumulation and hepatic triglyceride content in ovariectomized rats fed a high-fat, high-fructose diet (HFFD). (A) Representative photomicrographs of livers stained with hematoxylin and eosin (H&E) from sham rats fed a control diet (SHAM), ovariectomized rats fed an HFFD (OHFFD), OVX rats fed an HFFD and administered 20-hydroxyecdysone at a dose of 5, 10, or 20 mg/kg (OHFFD + 20E (5), OHFFD + 20E (10), and OHFFD + 20E (20), respectively), and OVX rats fed an HFFD and administered pioglitazone (OHFFD + PIO). Scale bar: 20 μm. (B) Hepatic triglyceride content. Data are mean ± SEM for six animals/group. * p < 0.05 and *** p < 0.001 between the indicated groups.
Figure 2 Effect of 20-hydroxyecdysone (20E) and pioglitazone (PIO) treatment on hepatic fat accumulation and hepatic triglyceride content in ovariectomized rats fed a high-fat, high-fructose diet (HFFD). (A) Representative photomicrographs of livers stained with hematoxylin and eosin (H&E) from sham rats fed a control diet (SHAM), ovariectomized rats fed an HFFD (OHFFD), OVX rats fed an HFFD and administered 20-hydroxyecdysone at a dose of 5, 10, or 20 mg/kg (OHFFD + 20E (5), OHFFD + 20E (10), and OHFFD + 20E (20), respectively), and OVX rats fed an HFFD and administered pioglitazone (OHFFD + PIO). Scale bar: 20 μm. (B) Hepatic triglyceride content. Data are mean ± SEM for six animals/group. * p < 0.05 and *** p < 0.001 between the indicated groups.CC BY · PubMed Central
Figure 3 Effects of 20-hydroxyecdysone (20E) and pioglitazone (PIO) treatment on hepatic AMP-activated protein kinase (AMPK) activity. (A) Representative immunoblots of total AMPKα, phosphorylated AMPKα (Thr172) and GAPDH. The blots were cropped, and full-length blots are presented in Supplementary Figure S1. (B) Quantitative blot analysis of total AMPKα expression, normalized to GAPDH, (C) Quantitative blot analysis of phosphorylated AMPKα (Thr172), normalized to GAPDH, and (D) Ratio of phosphorylated AMPKα (Thr172) to total AMPKα expression (pAMPKα (Thr172)/AMPKα), which represents AMPK activity, in sham-operated rats (Sham) fed a control diet, ovariectomized (OVX) rats fed a high-fat, high-fructose diet (OHFFD), OVX rats fed an HFFD and administered 20-hydroxyecdysone (OHFFD + 20E) at a dose of 5, 10, or 20 mg/kg, and OVX rats fed an HFFD and administered pioglitazone (OHFFD + PIO). The band intensities for pAMPKα (Thr172), AMPKα, and GAPDH were measured, and the data are presented as the fold differences in expression vs. the Sham group. Data are mean ± SEM for six animals/group. * p < 0.05, ** p < 0.01, and *** p < 0.001 between the indicated groups.
Figure 3 Effects of 20-hydroxyecdysone (20E) and pioglitazone (PIO) treatment on hepatic AMP-activated protein kinase (AMPK) activity. (A) Representative immunoblots of total AMPKα, phosphorylated AMPKα (Thr172) and GAPDH. The blots were cropped, and full-length blots are presented in Supplementary Figure S1. (B) Quantitative blot analysis of total AMPKα expression, normalized to GAPDH, (C) Quantitative blot analysis of phosphorylated AMPKα (Thr172), normalized to GAPDH, and (D) Ratio of phosphorylated AMPKα (Thr172) to total AMPKα expression (pAMPKα (Thr172)/AMPKα), which represents AMPK activity, in sham-operated rats (Sham) fed a control diet, ovariectomized (OVX) rats fed a high-fat, high-fructose diet (OHFFD), OVX rats fed an HFFD and administered 20-hydroxyecdysone (OHFFD + 20E) at a dose of 5, 10, or 20 mg/kg, and OVX rats fed an HFFD and administered pioglitazone (OHFFD + PIO). The band intensities for pAMPKα (Thr172), AMPKα, and GAPDH were measured, and the data are presented as the fold differences in expression vs. the Sham group. Data are mean ± SEM for six animals/group. * p < 0.05, ** p < 0.01, and *** p < 0.001 between the indicated groups.CC BY · PubMed Central
Figure 4 Effects of 20-hydroxyecdysone (20E) and pioglitazone (PIO) treatment on the expression of the rate-limiting enzyme of fatty acid metabolism and its regulator, and the rate-limiting enzyme of fatty acid β-oxidation in the liver. (A) Representative immunoblots for total ACC, phosphorylated ACC (Ser79), FAS, and GAPDH. The blots were cropped, and full-length blots are presented in Supplementary Figure S2. (B) Quantitative analysis of total ACC expression, normalized to GAPDH, (C) Quantitative analysis of phosphorylated ACC (Ser79), normalized to GAPDH, (D) Ratio of phosphorylated ACC (Ser79) to total ACC (pACC (Ser79)/ACC), which represents ACC activity, (E) Quantitative analysis of FAS, normalized to GAPDH, (F) Representative immunoblots of CPT-1, normalized to GAPDH, the blots were cropped and full-length blots are presented in Supplementary Figure S3. (G) Quantitative analysis of CPT-1, normalized to GAPDH for sham-operated rats (Sham) fed a control diet, ovariectomized (OVX) rats fed a high-fat, high-fructose diet (OHFFD), OVX rats fed an HFFD and administered 20-hydroxyecdysone (OHFFD + 20E) at a dose of 5, 10, or 20 mg/kg, and OVX rats fed an HFFD and administered pioglitazone (OHFFD + PIO). The band intensities for pACC (Ser79), ACC, and GAPDH were measured, and the data are presented as the fold differences in expression relative to the Sham group. Data are mean ± SEM for six animals/group. * p < 0.05, ** p < 0.01, and *** p < 0.001 between the indicated groups.
Figure 4 Effects of 20-hydroxyecdysone (20E) and pioglitazone (PIO) treatment on the expression of the rate-limiting enzyme of fatty acid metabolism and its regulator, and the rate-limiting enzyme of fatty acid β-oxidation in the liver. (A) Representative immunoblots for total ACC, phosphorylated ACC (Ser79), FAS, and GAPDH. The blots were cropped, and full-length blots are presented in Supplementary Figure S2. (B) Quantitative analysis of total ACC expression, normalized to GAPDH, (C) Quantitative analysis of phosphorylated ACC (Ser79), normalized to GAPDH, (D) Ratio of phosphorylated ACC (Ser79) to total ACC (pACC (Ser79)/ACC), which represents ACC activity, (E) Quantitative analysis of FAS, normalized to GAPDH, (F) Representative immunoblots of CPT-1, normalized to GAPDH, the blots were cropped and full-length blots are presented in Supplementary Figure S3. (G) Quantitative analysis of CPT-1, normalized to GAPDH for sham-operated rats (Sham) fed a control diet, ovariectomized (OVX) rats fed a high-fat, high-fructose diet (OHFFD), OVX rats fed an HFFD and administered 20-hydroxyecdysone (OHFFD + 20E) at a dose of 5, 10, or 20 mg/kg, and OVX rats fed an HFFD and administered pioglitazone (OHFFD + PIO). The band intensities for pACC (Ser79), ACC, and GAPDH were measured, and the data are presented as the fold differences in expression relative to the Sham group. Data are mean ± SEM for six animals/group. * p < 0.05, ** p < 0.01, and *** p < 0.001 between the indicated groups.CC BY · PubMed Central
Figure 5 Effects of 20-hydroxyecdysone (20E) and pioglitazone (PIO) treatment on AMP-activated protein kinase (AMPK) activity in periovarian white adipose tissue. (A) Representative immunoblots of total AMPKα, phosphorylated AMPKα (Thr172), and GAPDH. The original blots are presented in Supplementary Figure S4. (B) Quantitative analysis of total AMPKα expression, normalized to GAPDH, (C) Quantitative analysis of phosphorylated AMPKα (Thr172), normalized to GAPDH, and (D) Ratio of phosphorylated AMPKα (Thr172) to total AMPKα (pAMPKα (Thr172)/AMPKα), which represents AMPK activity, for sham-operated rats (Sham) fed a control diet, ovariectomized (OVX) rats fed a high-fat, high-fructose diet (OHFFD), OVX rats fed an HFFD and administered 20-hydroxyecdysone (OHFFD + 20E) at a dose of 5, 10, or 20 mg/kg, and OVX rats fed an HFFD and administered pioglitazone (OHFFD + PIO). The band intensities for pAMPKα (Thr172), AMPKα, and GAPDH were measured, and data are presented as the fold differences in expression relative to the Sham group. Data are mean ± SEM for six animals/group. * p < 0.05, ** p < 0.01, and *** p < 0.001 between the indicated groups.
Figure 5 Effects of 20-hydroxyecdysone (20E) and pioglitazone (PIO) treatment on AMP-activated protein kinase (AMPK) activity in periovarian white adipose tissue. (A) Representative immunoblots of total AMPKα, phosphorylated AMPKα (Thr172), and GAPDH. The original blots are presented in Supplementary Figure S4. (B) Quantitative analysis of total AMPKα expression, normalized to GAPDH, (C) Quantitative analysis of phosphorylated AMPKα (Thr172), normalized to GAPDH, and (D) Ratio of phosphorylated AMPKα (Thr172) to total AMPKα (pAMPKα (Thr172)/AMPKα), which represents AMPK activity, for sham-operated rats (Sham) fed a control diet, ovariectomized (OVX) rats fed a high-fat, high-fructose diet (OHFFD), OVX rats fed an HFFD and administered 20-hydroxyecdysone (OHFFD + 20E) at a dose of 5, 10, or 20 mg/kg, and OVX rats fed an HFFD and administered pioglitazone (OHFFD + PIO). The band intensities for pAMPKα (Thr172), AMPKα, and GAPDH were measured, and data are presented as the fold differences in expression relative to the Sham group. Data are mean ± SEM for six animals/group. * p < 0.05, ** p < 0.01, and *** p < 0.001 between the indicated groups.CC BY · PubMed Central
Figure 6 Effects of 20-hydroxyecdysone (20E) and pioglitazone (PIO) treatment on the expression of the rate-limiting enzyme in fatty acid metabolism, its regulator, and the rate-limiting enzyme of fatty acid β-oxidation in periovarian white adipose tissue. (A) Representative immunoblots of total ACC, phosphorylated ACC (Ser79), FAS, and GAPDH. The blots were cropped, and full-length blots are presented in Supplementary Figure S5. (B) Quantitative analysis of total ACC expression, normalized to GAPDH, (C) Quantitative analysis of phosphorylated ACC (Ser79), normalized to GAPDH, (D) Ratio of phosphorylated ACC (Ser79) to total ACC (pACC (Ser79)/ACC), which represents ACC activity, (E) Quantitative analysis of FAS, normalized to GAPDH, (F) Representative immunoblots of SREBP-1c, normalized to GAPDH. The original blots are presented in Supplementary Figure S6, and (G) Quantitative analysis of SREBP-1c, normalized to GAPDH for sham-operated rats (Sham) fed a control diet, ovariectomized (OVX) rats fed a high-fat, high-fructose diet (OHFFD), OVX rats fed an HFFD and administered 20-hydroxyecdysone (OHFFD + 20E) at a dose of 5, 10, or 20 mg/kg, and OVX rats fed an HFFD and administered pioglitazone (OHFFD + PIO). The band intensities for pACC (Ser79), ACC, and GAPDH are presented as the fold differences in expression relative to the Sham group. Data are mean ± SEM for six animals/group. * p < 0.05, ** p < 0.01, and *** p < 0.001 between the indicated groups.
Figure 6 Effects of 20-hydroxyecdysone (20E) and pioglitazone (PIO) treatment on the expression of the rate-limiting enzyme in fatty acid metabolism, its regulator, and the rate-limiting enzyme of fatty acid β-oxidation in periovarian white adipose tissue. (A) Representative immunoblots of total ACC, phosphorylated ACC (Ser79), FAS, and GAPDH. The blots were cropped, and full-length blots are presented in Supplementary Figure S5. (B) Quantitative analysis of total ACC expression, normalized to GAPDH, (C) Quantitative analysis of phosphorylated ACC (Ser79), normalized to GAPDH, (D) Ratio of phosphorylated ACC (Ser79) to total ACC (pACC (Ser79)/ACC), which represents ACC activity, (E) Quantitative analysis of FAS, normalized to GAPDH, (F) Representative immunoblots of SREBP-1c, normalized to GAPDH. The original blots are presented in Supplementary Figure S6, and (G) Quantitative analysis of SREBP-1c, normalized to GAPDH for sham-operated rats (Sham) fed a control diet, ovariectomized (OVX) rats fed a high-fat, high-fructose diet (OHFFD), OVX rats fed an HFFD and administered 20-hydroxyecdysone (OHFFD + 20E) at a dose of 5, 10, or 20 mg/kg, and OVX rats fed an HFFD and administered pioglitazone (OHFFD + PIO). The band intensities for pACC (Ser79), ACC, and GAPDH are presented as the fold differences in expression relative to the Sham group. Data are mean ± SEM for six animals/group. * p < 0.05, ** p < 0.01, and *** p < 0.001 between the indicated groups.CC BY · PubMed Central
Figure 7 Proposed mechanism by which 20E supplementation reduces visceral fat mass and hepatic fat accumulation. Long-term high-fat-high-fructose diet and ovariectomy increase visceral and liver fat accumulation. 20E increases the phosphorylation of AMPK and ACC but decreases fatty acid synthase in the liver and adipose tissue, thereby reducing lipogenesis. 20E also increases hepatic CPT-1 and reduces the adipose SREBP-1c expression, thereby increasing fatty acid β-oxidation and reducing lipid biosynthesis and adipogenesis.
Figure 7 Proposed mechanism by which 20E supplementation reduces visceral fat mass and hepatic fat accumulation. Long-term high-fat-high-fructose diet and ovariectomy increase visceral and liver fat accumulation. 20E increases the phosphorylation of AMPK and ACC but decreases fatty acid synthase in the liver and adipose tissue, thereby reducing lipogenesis. 20E also increases hepatic CPT-1 and reduces the adipose SREBP-1c expression, thereby increasing fatty acid β-oxidation and reducing lipid biosynthesis and adipogenesis.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 60 references

Cited by

See all 9

Metadata

Authors
Buniam, J., Chansela, P., Weerachayaphorn, J., & Saengsirisuwan, V.
Affiliations
  • Chulabhorn Royal Academy (TH)
  • Phramongkutklao College of Medicine (TH)
  • Mahidol University (TH)
Corresponding author
Saengsirisuwan, Vitoon
Venue
Biomedicines
Publisher
MDPI AG
Published
2023-07-23
Volume
11
Issue
7
Pages
2071
ISSN
2227-9059 (ISSN-L)
OpenAlex
W4385201650
Cited by
9
References
60
Citations by year
2026: 4 · 2025: 2 · 2024: 3
FWCI
1.80
Type
journal article
Language
en
Open access
Locations
  • Biomedicines (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
  • Mahidol University (640200017397000)
  • Chulabhorn Royal Academy (640200017397000)
Topics
  • Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diet, Metabolism, and Disease
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Lipid metabolism and biosynthesis
Keywords
20-hydroxyecdysone, non-alcoholic fatty liver disease, hepatic steatosis, white adipose tissue, high-fat high-fructose diet, ovariectomy, AMPK, acetyl-CoA carboxylase, fatty acid synthase, carnitine palmitoyltransferase 1, SREBP1, lipogenesis, dietary supplementation

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Dietary Supplementation with 20-Hydroxyecdysone Ameliorates Hepatic Steatosis and Reduces White Adipose Tissue Mass in Ovariectomized Rats Fed a High-Fat, High-Fructose Diet. https://app.cochat.ai/papers/10.3390/biomedicines11072071
The paper
Buniam, J., Chansela, P., Weerachayaphorn, J., & Saengsirisuwan, V. (2023). Dietary Supplementation with 20-Hydroxyecdysone Ameliorates Hepatic Steatosis and Reduces White Adipose Tissue Mass in Ovariectomized Rats Fed a High-Fat, High-Fructose Diet. Biomedicines. https://doi.org/10.3390/biomedicines11072071

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.